Correlation Between Neuropace and Medigus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Medigus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Medigus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Medigus Ltd ADR, you can compare the effects of market volatilities on Neuropace and Medigus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Medigus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Medigus.

Diversification Opportunities for Neuropace and Medigus

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Neuropace and Medigus is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Medigus Ltd ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigus Ltd ADR and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Medigus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigus Ltd ADR has no effect on the direction of Neuropace i.e., Neuropace and Medigus go up and down completely randomly.

Pair Corralation between Neuropace and Medigus

Given the investment horizon of 90 days Neuropace is expected to generate 1.06 times more return on investment than Medigus. However, Neuropace is 1.06 times more volatile than Medigus Ltd ADR. It trades about 0.09 of its potential returns per unit of risk. Medigus Ltd ADR is currently generating about -0.15 per unit of risk. If you would invest  691.00  in Neuropace on August 29, 2024 and sell it today you would earn a total of  334.00  from holding Neuropace or generate 48.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy11.11%
ValuesDaily Returns

Neuropace  vs.  Medigus Ltd ADR

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Medigus Ltd ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigus Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Medigus is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Neuropace and Medigus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Medigus

The main advantage of trading using opposite Neuropace and Medigus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Medigus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigus will offset losses from the drop in Medigus' long position.
The idea behind Neuropace and Medigus Ltd ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing